Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.
Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland.
Cancer Cytopathol. 2023 May;131(5):289-299. doi: 10.1002/cncy.22679. Epub 2023 Jan 17.
Rather than surgical resection, cytologic specimens are often used as first-line clinical diagnostic procedures due to higher safety, speed, and cost-effectiveness. Archival diagnostic cytology slides containing cancer can be equivalent to tissue biopsies for DNA mutation testing, but the accuracy of transcriptomic profiling by RNA sequencing (RNA-seq) is less understood.
This study compares the results from whole transcriptome RNA-seq and a targeted RNA-seq assay of stained cytology smears (CS) versus matched tumor tissue samples preserved fresh-frozen (FF) and processed as formalin-fixed paraffin-embedded (FFPE) sections. Cellular cytology scrapes from all 11 breast cancers were fixed and stained using three common protocols: Carnoy's (CS_C) or 95% ethanol (CS_E) fixation and then Papanicolaou stain or air-dried then methanol fixation and DiffQuik stain (CS_DQ). Agreement between samples was assessed using Lin's concordance correlation coefficient.
Library yield for CS_DQ was too low, therefore it was not sequenced. The distributions of concordance correlation coefficient of gene expression levels in comparison to FF were comparable between CS_C and CS_E, but expression of genes enriched in stroma was lower in cytosmear samples than in FF or FFPE. Six signatures showed similar concordance to FF for all methods and two were slightly worse in CS_C and CS_E. Genomic signatures were highly concordant using targeted RNA-seq. The allele fraction of selected mutations calculated on cytosmear specimens was highly correlated with FF tissues using both RNA-seq methods.
RNA can be reliably extracted from cytology smears and is suitable for transcriptome profiling or mutation detection, except for signatures of tumor stroma.
由于安全性更高、速度更快、更具成本效益,细胞学标本通常被用作一线临床诊断程序,而非手术切除。包含癌症的存档诊断细胞学载玻片可与组织活检一样用于 DNA 突变检测,但 RNA 测序(RNA-seq)转录组谱分析的准确性则知之甚少。
本研究比较了全转录组 RNA-seq 与靶向 RNA-seq 检测染色细胞学涂片(CS)与新鲜冷冻(FF)保存的匹配肿瘤组织样本和经福尔马林固定石蜡包埋(FFPE)处理的组织样本的结果。11 例乳腺癌的细胞细胞学刮片分别用三种常见的方案固定和染色:Carnoy's(CS_C)或 95%乙醇(CS_E)固定,然后行巴氏染色或空气干燥后甲醇固定,然后行 DiffQuik 染色(CS_DQ)。采用 Lin 的一致性相关系数评估样本间的一致性。
CS_DQ 的文库产量太低,因此未进行测序。CS_C 和 CS_E 与 FF 相比,基因表达水平的一致性相关系数分布相似,但细胞涂片样本中富含基质的基因表达水平低于 FF 或 FFPE。6 个签名在所有方法中与 FF 具有相似的一致性,而在 CS_C 和 CS_E 中则略差。靶向 RNA-seq 可高度一致地检测基因组签名。使用两种 RNA-seq 方法,在计算选定突变的等位基因分数时,细胞学标本与 FF 组织高度相关。
RNA 可从细胞学标本中可靠提取,适用于转录组谱分析或突变检测,但肿瘤基质的特征除外。